the differences, the vast differences, between an ambulatory patient and an institutional patient."
Because CMS does not allow Part D plans to count as MTM a consultant pharmacist's monthly review of institutionalized patients' drug regimens, McMahan said, Humana will have to develop other MTM services for these patients that offer a meaningful and measurable benefit.
Baggett said that coordination of care between skilled-nursing-facility staff and Aetna's pharmacotherapy specialists is included in the company's MTM program for institutionalized patients. She noted that long-term-care pharmacists are expected to be "a huge resource of information" for Aetna's MTM staff.
What lies ahead. Despite CMS's initial hands-off approach to Part D sponsors' MTM programs, the agency has stated that it expects MTM to improve patient outcomes and reduce Medicare's health care costs in the long run. CMS could use information gained from this year's MTM programs to devise specific requirements for future programs.
The drug plans, in turn, know that CMS is paying attention to the emerging field of MTM. "It's a complex program, we're on a tight budget, and we have to be able to say to CMS that we used the dollars appropriately when all is said and done," McMahon said.
-Kate Traynor DOI 10.2146/news050041
Continued on page 24
Continued from page 18
Six new members join AJHP editorial board AJHP welcomes six new editorial board members whose term of service begins with this issue of the Journal. Each board member will serve for three years and will be responsible for reviewing articles submitted to AJHP, recruiting authors and reviewers for the journal, and providing expertise to AJHP staff about important issues in contemporary pharmacy practice.
Gerard R. Barber, M.P.H., is Pharmacy Specialist for Antiinfectives at Lakeland Regional Medical Center in Florida. His professional interests include infection control and public health issues, as well as the study and treatment of infections in immunocompromised patients, fungal infections, and surgical-site infections. Barber's leadership roles include serving as cochair of Lakeland's antibiotic subcommittee and cocaptain of the bicycling team for the local Multiple Sclerosis Society chapter. Barber considers his most important practice achievement to be the conducting of comparative studies assessing the risk for surgical-site infection in general surgical patients and those with cancer-studies that achieved recognition by practitioners outside the pharmacy profession. During his tenure on the editorial board, Barber would like to see AJHP publish more scientific and informational articles from young investigators and from pharmacists working in community practices and universityaffiliated teaching sites. He would also like to encourage the publication of articles involving public health issues and epidemiology.
Jill force on clinical practice management. Among Hoffman's memorable practice achievements are the completion of a combined residency in health-system pharmacy and administration and a fellowship in outcomes research. During his term of service to AJHP, Hoffman would like the journal to encourage the publication of articles from new practitioners and promote the publication of systematic reviews and meta-analyses of studies related to drug therapy. Nathan's main professional focus is on drug information centers and services and patient drug-information literacy. He has chaired the college's task force on the development of a nontraditional Pharm.D. pathway and the self-study subcommittee on students and been an active member on numerous other committees at the school. Nathan's professional accomplishments include successfully maintaining simultaneous practices in academic, hospital, and community pharmacy settings, as well as serving as a consultant pharmacist to long-term-care facilities. Nathan hopes to use his various practice experiences to help AJHP publish high-quality articles that satisfy the interests of all readers. Working with his fellow board members, Nathan wants to help identify emerging trends in pharmacy that merit publication in the journal. DOI 10.2146/news050042 
-Kate Traynor

